Regional Sales Director - Detroit
Mineralys Therapeutics
Summary
The Regional Sales Director (RSD) will play a critical role in the successful launch and growth of Mineralys' first commercial product within an assigned region. This leader will be accountable for translating national strategy into regional execution, driving business performance through strong field leadership, cross-functional partnership, and disciplined execution against launch objectives. The RSD will build and lead a high-performing team of territory managers, foster deep customer relationships, and ensure alignment with corporate priorities, compliance standards, and Mineralys' values.
Job description
Key Responsibilities
Commercial Leadership / Launch Execution
- Lead all regional launch planning and execution activities to ensure successful market entry and sustained product uptake
- Translate national brand strategy into actionable regional business plans and field execution priorities
- Lead team to achieve or exceed sales goals, market share targets, and key performance metrics at launch and beyond
- Monitor market dynamics, customer feedback, and competitive intelligence to adjust strategy in real time
- Drive accountability for performance through data-driven decision making and disciplined execution
Team Leadership / Coaching
- Recruit, onboard, develop, and retain top-performing territory managers across the region
- Lead, coach, and motivate a team of approximately 8–12 territory managers
- Establish and maintain high level of disease state, clinical and product knowledge
- Evaluate performance of territory managers and coach to skill and career development through regular field contact
- Foster a high-performance culture focused on accountability, collaboration, and continuous improvement
- Build strong succession plans and talent pipelines
Customer / Market Engagement
- Develop and maintain relationships with key healthcare providers, health systems, integrated delivery networks (IDNs) and strategic accounts
- Partner with territory managers on key customer interactions, access challenges, and develop account strategies
- Support pull-through with IDNs, organized customers, and priority accounts
- Timely and effectively share customer insights with internal stakeholders
Cross-Functional Collaboration
- Partner closely with Market Access, Marketing, Medical Affairs, Training, Operations, and HR to support launch readiness and execution
- Provide field-driven input into brand planning, messaging, and tactical adjustments
- Collaborate with Area Sales Directors and peers to share best practices and drive consistency across regions
- Support national meetings, launch planning sessions, and field communications
Compliance / Operational Excellence
- Ensure all regional activities are conducted in full compliance with company policies, industry regulations, and legal standards
- Manage regional budgets and resources effectively
- Maintain accurate forecasting, CRM utilization, and reporting discipline
- Uphold Mineralys' values of collaboration, integrity, quality, trust, and urgency
Requirements
- Bachelor's degree required; advanced degree preferred
- 8+ years of pharmaceutical / biotech sales experience
- 3+ years of people leadership experience in a district / regional manager role
- Proven success leading specialty sales teams and exceeding performance goals
- Prior launch experience required; first-launch / startup biotech experience strongly preferred
- Experience in cardiovascular, nephrology, hypertension, or related specialty markets strongly preferred
- Demonstrated success in recruiting and developing top talent
- Strong business planning, analytical, and coaching skills
- Ability to work effectively in a fast-paced, highly collaborative environment
- Willingness to travel extensively within region
Benefits
- Medical, Dental & Vision
- Time off
- 401(k)
- Incentive plans
Company overview
Mineralys Therapeutics is a clinical-stage biopharmaceutical company founded in 2020 and headquartered in Radnor, Pennsylvania. The company is dedicated to developing novel, targeted therapies for hypertension and cardio-renal-metabolic diseases, with a particular focus on addressing dysregulated aldosterone biology. Mineralys' lead candidate, lorundrostat (MLS-101), is a highly selective aldosterone synthase inhibitor that represents a new approach to hypertension treatment by targeting the underlying cause of elevated aldosterone in approximately 30% of hypertension patients. The company has advanced lorundrostat through Phase 2 clinical trials and is currently conducting Phase 3 studies, with its Launch-HTN trial recently recognized by the Journal of the American Medical Association (JAMA) in their inaugural 'Research of the Year' roundup. Mineralys aims to redefine hypertension management by moving beyond the traditional 'trial and failure' approach to offer personalized treatment options for patients with uncontrolled or treatment-resistant hypertension.